Kirk Falconer

Fund III, launched last November, has to date secured more than $1.6bn, 24% above its original target.

The pandemic might have had a beneficial effect on fundraising by “highlighting how impactful healthcare innovation can be,” Sagard's David MacNaughtan told Buyouts.

Fund VI was “very significantly oversubscribed,” president and CEO Pascal Tremblay told Buyouts, with Novacap “more than doubling” the size of its investor base.

Brookfield’s fundraising plans include a debut energy transition offering with a target of more than $7.5bn. The firm is committing $2bn.

Fund III appears to be the first offering launched since the 2020 succession, which saw founders Arthur Levine and Lauren Leichtman step back from daily operations.

AG Direct Lending Fund IV, targeting $2bn with a $3bn hard cap, is expected to wrap up in the first quarter.

Monomoy's latest deal, announced last month, saw it acquire Astro Shapes, a manufacturer of custom-finished aluminum extrusions.

Last year’s results owe in part to GPs and LPs adapting quickly to virtual fundraising, making it possible to wrap up even multi-billion-dollar pools expeditiously.

Because of the resiliency of its portfolio during the health crisis, Seaside “didn’t think of delaying” Fund I’s launch, managing director Andrew Thompson told Buyouts.

HIG created the strategic partners option to give select limited partners the opportunity to invest in forthcoming multi-strategy offerings.